Status:
COMPLETED
Cellular and Humoral Immunity in Elderly After Immunization With a Japanese Encephalitis Vaccine
Lead Sponsor:
Medical University of Vienna
Conditions:
Humoral and Cellular Immune Responses
Eligibility:
All Genders
18-99 years
Phase:
PHASE4
Brief Summary
The aim of this project is to investigate humoral and cellular immune responses before and after immunisation with the Japanese encephalitis vaccine IXIARO in subjects above 60 years of age and 18-40 ...
Eligibility Criteria
Inclusion
- adults (18-40 years old)
- adults (≥60 years),
- both sexes
- willingness to sign written informed consent form
Exclusion
- age below 18 years or between 41-59 years old
- status post japanese encephalitis, tick born encephalitis (TBE), dengue, yellow fever or West Nile virus infection
- previous immunization against yellow fever, japanese encephalitis (dengue or WNV)
- current acute infection (body temperature above 37,9°C)
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01398540
Start Date
November 1 2010
End Date
November 1 2013
Last Update
March 29 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.